Silicon Valley Capital Partners

Position in RGNX — REGENXBIO Inc.

CIK 1673633 SAN JOSE, CA

Position in RGNX

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$100

New position

Shares Held

12

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Silicon Valley Capital Partners holds $7,195 across 6 Biotechnology names. RGNX ranks #5 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	67	$3,532
2	REGN	Regeneron Pharmaceuticals, Inc.	4	$3,090
3	ZNTL	Zentalis Pharmaceuticals, Inc.	84	$196
4	WVE	Wave Life Sciences Ltd.	25	$181
5	RGNX	REGENXBIO Inc. This page	12	$100
6	FLNA	Filana Therapeutics, Inc.	57	$96

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$100	12	—	Shares	Sole	2026-05-19
No filing history on record for this holder in this stock.